PATENT CLAIM ANALYSIS

Application Number: 15878288
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "009600"]

Abstract:
A method for mitigating the effects of traumatic brain injury in an individual comprising is disclosed. The method includes administering an amount of a composition prior to a period wherein the traumatic brain injury is expected to occur, wherein the composition is comprised of: 300 mg and 500 milligrams (mg) of Docosahexaenoic acid (DHA), 50 mg/kg to 400 mg/kg (milligrams of composition per kilogram of body weight of the individual) of curcumin, and 10 mg to 100 mg of resveratrol. In some embodiments, the composition may include 350 mg of DHA, 150 mg/kg of curcumin and 30 mg of resveratrol. In additional embodiments, the composition may further include α-linoleic acid of an amount within the range of, for example, 1-2 g. The composition may be administered to the individual within a predetermined amount of time prior to a period wherein the traumatic brain injury is expected to occur.

Claim (Index 9):
The method of  claim 4 , wherein the composition is administered orally to the individual.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 2.28767
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13637239', '13718065', '13408689', '15417943', '14772035']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7361424267831352
- 35 USC 102 Novelty (BERT): 0.5094269181740658
- Combined Prediction Score: 0.7134708759222284
- Mean Citation Score: 205.623252
- Max Citation Score: 227.27132000000003
- Similarity Product: 135.07271705667495

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test